Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Progyny, Inc., a leader in women's health and family-building solutions, announced that its current annual selling season is pacing to a record level with an expected addition of 1.2 million new covered lives in the first half of 2027. The company's fertility solutions address rising medical cost inflation by offering employers programs that improv…
SciSparc Ltd., through its majority-owned subsidiary NeuroThera Labs and further its subsidiary CliniQuantum, announced a successful demonstration of a quantum-enabled GPU-accelerated platform that analyzed over 7 billion potential three-gene combinations in real-world clinical data. Utilizing a single NVIDIA T4 GPU, their platform achieved approxi…
Akita Drilling's purchase of Fox Drilling meaningfully expands its operational footprint in North America. The combination should drive higher utilization and revenue optionality; given a $147M market cap and depressed share price versus the 52-week high, there's a tradeable long with defined risk. This idea lays out entry, stop, targets, catalysts…
SeaStar Medical received FDA Breakthrough Device Designation for its Selective Cytopheretic Device (SCD) therapy to treat hyperinflammation in adult patients with sepsis or septic conditions. This designation accelerates development and review processes, marking the seventh breakthrough designation for the SCD platform across multiple indications. …
FuelCell Energy, Inc. announced a planned transition in its CFO position with Michael Bishop stepping down after 15 years and Matthew Latino succeeding him. The company reaffirmed its target to achieve positive Adjusted EBITDA in Q4 fiscal 2027, contingent on production increases and backlog conversion. FuelCell Energy is focused on scaling manufac…
MAIA Biotechnology announced completion of patient enrollment in Part C of its Phase 2 THIO-101 trial and achieving 65% enrollment in its pivotal Phase 3 THIO-104 trial investigating ateganosine combined with checkpoint inhibitors for treatment of advanced non-small cell lung cancer (NSCLC). Interim Phase 2 data show high disease control rates sign…
VivoSim Labs celebrates the FDA's updated regulations officially permitting the use of non-animal New Approach Methodologies (NAMs), including VivoSim's 3D human tissue models, for drug safety testing. This advancement potentially increases clinical trial success rates and reduces drug development costs by enabling earlier identification of toxic d…
ExlService Holdings, Inc., a global data and AI company, will release its financial results for the third quarter ended September 30, 2026, on October 27, after market close. The company will host a conference call on October 28 featuring executives discussing operational and financial outcomes. EXL serves multiple industries including insurance, h…
Safe Pro Group Inc., a U.S.-based AI-enabled defense and security solutions company, announced preliminary expectations of a 2,300% year-over-year revenue growth in Q3 2026, driven by multiple U.S. Army and Air Force subcontracts. The company's innovative AI threat detection and battlefield mapping technology is gaining traction with government age…
Skyworks Solutions announced that its Si829x isolated safety gate driver featuring ProVCD™ technology has completed AEC-Q100 automotive qualification and is now available for customer evaluation and prototyping. The device supports SiC FETs and IGBTs, targets scalable high-performance inverter architectures, and offers safety features suitable for …
Esperion Therapeutics has reached a settlement agreement with Renata Limited preventing the marketing of generic versions of its cholesterol-lowering drugs NEXLETOL and NEXLIZET in the US until April 19, 2040, reinforcing its patent protection. Ongoing litigations with other generic filers continue. Esperion, wholly owned by ARCHIMED, focuses on ca…
WillScot Holdings Corporation has elected Donald Slager, former CEO of Republic Services, to its Board of Directors as an independent director. Slager brings extensive experience in corporate governance and leadership during transformative periods, expected to support WillScot's long-term strategic objectives. He joins key committees to aid governa…
Jasper Therapeutics announced an offer to purchase all outstanding warrants issued during its 2025 public offering, aiming to reduce potential dilution of its common stock. The company will pay $0.324 per warrant in cash to buy back up to approximately 12.3 million warrants, representing a $4 million cash outlay. The offer is open until November 6,…
Virtu Financial, a global multi-asset financial services provider, will release its third quarter 2026 earnings on November 5, 2026, before the US market opens. The company will hold a conference call and webcast to discuss the results, focusing on its global liquidity and trading solutions across various asset classes.
Pacira BioSciences and the Caregiver Action Network conducted a national survey revealing that family caregivers often feel unprepared to manage postsurgical pain and recovery at home. The survey highlights gaps in communication about pain management options, especially non-opioid therapies, and underscores caregivers’ need for clearer, practical i…
Akebia Therapeutics announced that key executives will participate in one-on-one meetings at the virtual U.S. Bancorp I BTIG Kidney Health Forum, discussing their commercial products and clinical pipeline focused on rare kidney diseases.
Roundtable (NASDAQ: RTB), an AI and DeFi-powered Enterprise Media Operating System, announced Erin Schaefer, former senior executive at Google, YouTube, and Niantic Games, has joined its Board of Directors. Schaefer brings extensive experience in scaling multi-billion-dollar commercial media businesses and strategic leadership in technology and bra…
Kyverna Therapeutics announced presentation of encouraging one-year data from its pivotal Phase 2 trial of miv-cel, a CD19 CAR T-cell therapy, in stiff person syndrome (SPS), showing sustained clinical benefit and a favorable safety profile. Additionally, updated positive Phase 1 data in progressive multiple sclerosis (MS) will be shared. These res…
Texas Capital Bancshares, Inc. will release its third quarter 2026 financial results after market close on October 21, 2026, followed by a conference call and webcast hosted by executive management to discuss operating results. The company provides comprehensive financial services in commercial, consumer, corporate and investment banking, with mult…
Sunrun Inc., America's leading home solar and battery storage provider, announced its third quarter 2026 earnings release date set for November 4, 2026, followed by an investor conference call to discuss the results.
Mobilicom Limited announced its participation at AUSA 2026 where it will showcase a new cybersecure communication solution designed for autonomous defense operations, addressing increasing data demands. Additionally, the company will present its business and growth opportunities in the drone, robotics, and defense sectors at the ThinkEquity investo…
Ironwood is a small-cap biotech trading at bargain multiples backed by solid LINZESS economics and meaningful free cash flow. The stock is fundamentally a call on the company executing and advancing a second Phase 3 apraglutide trial requested by regulators. If the company proves the program is on track, the re-rating can be substantial; failure or…
OR Royalties reported Q3 deliveries of 20,237 GEOs and $90.2M of revenue with a cash margin of 96.8%, left $76.7M of cash on the balance sheet, and still has significant available lending capacity. The stock trades at $34.47, well below a 52-week high of $48.06; we see tactical upside to $40.00 on continued GEO delivery growth, accretive small acqu…
dLocal's rapid TPV growth and exceptional net retention argue that recent margin compression is the byproduct of scaling into large enterprise flows and competitive pricing, not a permanent structural decline. At a $4.1B market cap and $14.53 stock price, the risk/reward favors a long, with a clear entry at $14.53, stop at $11.50 and a target of $2…
Nexentis Technologies has announced that its subsidiary MitoCareX Bio has deployed its computational drug discovery infrastructure on Google Cloud Platform, aiming to improve computational capacity, data governance, and operational flexibility. This strategic move is designed to support MitoCareX's evolving drug discovery programs by enabling scala…
